Trial Site Detail

 

Drug:
Imatinib, Nilotinib
Trial:
REGISTER: A multicentre phase 2 study of risk evaluation in GIST with selective therapy escalation for response
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting

 

Palmerston North Hospital

     
Palmerston North ,
New Zealand

 

Principal Investigator:
Garry Forgeson, MD
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Palmerston North Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.